Page 31 - GALENIKA MEDICAL JOURNAL

tretman srčane insuficijencije, te optimalne kontrole srčane literaturi se navodi da je kod 7,75% pacijenata sa simpto-
frekvencije i ritma 22, 24, 25 . mima akutnog koronarnog sindroma tokom pandemije
dijagnostikovana kardiomiopatija izazvana stresom, prven-
Bolest izazvana virusom korona (COVID-19) karakteriše stveno zbog straha od same pandemije i psiho-socijalnog
Virhovljeva trijada (endotelna disfunkcija, staza, hiperko- pritiska izazvanog pandemijom .
27
agulabilno stanje), koja leži u samoj osnovi COVID-19 . U
26

Zaključak

Kardiomiopatije predstavljaju cjelinu u kardiološkoj praksi koja se dijagnostički mora jasno
diferencirati, jer samo to vodi ka optimalnom terapijskom modalitetu.

Abstract

Cardiomyopathies are diseases of the heart muscle, and present a heterogeneous group of myocardial diseases with
mechanical or electrical dysfunction, characterized by ventricular hypertrophy or dilatation. They can be strictly related
to the heart muscle (primary), or as part of a systemic disease (secondary), and represent a factor that leads to a reduced
quality of life, the occurrence of heart failure and mortality. The primary ones are those that are genetic conditioning,
the mixed ones include dilated and restrictive cardiomyopathy, and the acquired ones are caused by myocarditis, stress-
induced, peripartum, tachycardia-induced and those caused by endocrine pathology (primarily in newborns of mothers
with a diagnosis of diabetes mellitus). Etiologically, they can arise as a result of a genetic mutation, an inflammatory
process, and they are also divided into metabolic, toxic and those caused by some other cause. The aim of the article was to
present the characteristics of cardiomyopathies themselves in relation to the etiological factor, with review of the diagnostic
and therapeutic modality.

Keywords: cardiomyopathy, dilated cardiomyopathy, treatment

Literatura 9. Jain P, Patel PA, Fabbro M 2nd. Hypertrophic Cardiomyopathy and Left
Ventricular Outflow Tract Obstruction: Expecting the Unexpected. J
Cardiothorac Vasc Anesth. 2018 Feb;32(1):467-77.
1. Brieler J, Breeden MA, Tucker J. Cardiomyopathy: An Overview. Am Fam 10. Mahmaljy H, Yelamanchili VS, Singhal M. Dilated Cardiomyopathy.
Physician. 2017 Nov 15;96(10):640-6. 2022 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls
2. Yacoub MH. Decade in review--cardiomyopathies: Cardiomyopathy on Publishing; 2022 Jan–.
the move. Nat Rev Cardiol. 2014 Nov;11(11):628-9. 11. Merlo M, Masè M, Perry A, La Franca E, Deych E, Ajello L, et al.
3. Westphal JG, Rigopoulos AG, Bakogiannis C, Ludwig SE, Mavrogeni Prognostic significance of longitudinal strain in dilated cardiomyopathy
S, Bigalke B, et al. The MOGE(S) classification for cardiomyopathies: with recovered ejection fraction. Heart. 2022 May;108(9):710-6.
current status and future outlook. Heart Fail Rev. 2017 Nov;22(6):743- 12. Basit H, Brito D, Sharma S. Hypertrophic Cardiomyopathy. 2022 Aug
52. 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;
4. Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: An 2022 Jan–.
Overview. Int J Mol Sci. 2021 Jul 19;22(14):7722. 13. Marian AJ. Molecular Genetic Basis of Hypertrophic Cardiomyopathy.
5. Authors/Task Force members; Elliott PM, Anastasakis A, Borger Circ Res. 2021 May 14;128(10):1533-53.
MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines 14. Brown KN, Pendela VS, Ahmed I, Diaz RR. Restrictive Cardiomyopathy.
on diagnosis and management of hypertrophic cardiomyopathy: 2022 Jul 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls
the Task Force for the Diagnosis and Management of Hypertrophic Publishing; 2022 Jan–.
Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart
J. 2014 Oct 14;35(39):2733-79. 15. Diez PD, Brugada J. Diagnosis and management of arrhythmogenic
6. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right right ventricular dysplasia. E-Journal of the ESC Council for Cardiology
Practice, 2008; 7(6).
ventricular cardiomyopathy. Lancet. 2009 Apr 11;373(9671):1289-300.
16. Singh DP, Patel H. Left Ventricular Non-compaction Cardiomyopathy.
7. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. 2022 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls
Classification of the cardiomyopathies: a position statement from the Publishing; 2022 Jan–.
European Society Of Cardiology Working Group on Myocardial and
Pericardial Diseases. Eur Heart J. 2008 Jan;29(2):270-6. 17. Ahmad SA, Brito D, Khalid N, Ibrahim MA. Takotsubo Cardiomyopathy.
2022 Mar 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls
8. Elliott PM. Classification of cardiomyopathies: evolution or revolution? J Publishing; 2022 Jan–.
Am Coll Cardiol. 2013 Dec 3;62(22):2073-4.
REVIJALNI RADOVI Galenika Medical Journal, 2023; 2(5):23-30. 29